| 000 | 03071nam a2200433 i 4500 | ||
|---|---|---|---|
| 988 | _aSpringer_BiomedLife_2019 | ||
| 999 |
_c115848 _d115848 _x1 |
||
| 001 | 115848 | ||
| 003 | ESmaUEC | ||
| 005 | 20230104140118.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 190903s2019 gw | s |||| 0|eng d | ||
| 020 | _a9783030310530 | ||
| 024 | 7 |
_a10.1007/978-3-030-31053-0 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQR185.8.F33 _b2019 EB |
|
| 245 | 0 | 0 |
_aFc Mediated Activity of Antibodies : _bStructural and Functional Diversity _cedited by Jeffrey V. Ravetch, Falk Nimmerjahn. |
| 250 | _a1st ed. 2019. | ||
| 264 | 1 |
_aCham, Switzerland _bSpringer International Publishing _c2019 |
|
| 300 |
_a1 recurso en línea (VII, 150 páginas) _b 14 ilustraciones, 12 ilustraciones a color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 |
_aCurrent Topics in Microbiology and Immunology _x0070-217X _v423 |
|
| 490 | 0 | _aBiomedical and Life Sciences (Springer-11642) | |
| 505 | 0 | _aIgG Fc receptors: evolutionary considerations -- Role of FcgRs in Antibody Based Cancer Therapy -- Anti-inflammatory Activity of IgG-Fc -- IgG Fc glycosylation in human immunity -- IgE Glycosylation in Health and Disease -- Immune Complex Vaccination -- Fc receptors in anti-microbial protection. | |
| 520 | 3 | _aThis volume explores several aspects of how antibodies mediate their activity in vivo, ranging from cancer immunotherapy to autoimmunity, infection, and vaccination. Divided into seven chapters, it provides in-depth insights into how antibodies and especially the antibody fragment crystallizable (Fc) domain modulate immune responses and antibody activity. The book begins by discussing evolutionary aspects of how the family of Fc receptors that are the key molecules for antibody activity evolved. In turn, it addresses the molecular and cellular pathways underlying IgG activity in cancer immunotherapy, and focuses on how IgG glycosylation regulates IgG and IgE activity in autoimmunity, allergy and infection. In closing, it presents strategies for developing novel antibody-based vaccination approaches. The book is intended for a very broad readership, including graduate students, postdocs and principal investigators with a basic grasp of immunology. | |
| 650 | 7 |
_2embne _aInmunología _9138330 |
|
| 650 | 7 |
_2embne _aProteínas _9139861 |
|
| 700 | 1 |
_aRavetch, Jeffrey V _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aNimmerjahn, Falk _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt _984739 |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783030310523 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030310547 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030310554 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-31053-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_aSI _cm _dz _feng _ggw _h0 _b01/2020 _ek _zSI |
||